Correction to: The AAPS Journal (2023) 25:87
The original article has been updated to correct a statement "The general guidelines for the maximum amount of allowed HCP impurities is 100 ng per mg of HCP.” to "The general guidelines for the maximum amount of allowed HCP impurities is 100 ng per mg of product.”
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Haltaufderhyde, K., Roberts, B.J., Khan, S. et al. Correction to: Immunoinformatic Risk Assessment of Host Cell Proteins During Process Development for Biologic Therapeutics. AAPS J 26, 6 (2024). https://doi.org/10.1208/s12248-023-00868-5
Published:
DOI: https://doi.org/10.1208/s12248-023-00868-5